Firm
The firm reported a small uptick in overall revenue and profit per equity partner, while its IP team secured notable life sciences victories
Paul Ainsworth, who secured a settlement for his client in a patent dispute, says the case shows why medical claims by dietary supplement companies can threaten IP rights
Boies Schiller Flexner joins forces with Grünecker to target Skechers in Europe following US lawsuit
Helen Mutimer discusses how the firm’s IP advisory services are filling a gap in the market, and why life sciences work is soaring
Sponsored
Sponsored
-
Sponsored by RNA, Technology and IP AttorneysRanjan Narula and Rajiv Suri of RNA, Technology and IP Attorneys consider a Supreme Court ruling where income from a software sale by non-resident companies to resident is not a ‘royalty’ payment -
Sponsored by Daniel LawCarolina Schueler of Daniel Law discusses why naming rights and sponsorship deals could be a profitable two-way partnership that may last for decades
-
Sponsored by IncoproSimon Baggs, CEO of Incopro, discusses the success of the group’s technology-led strategy and considers the key dynamics of the evolving brand protection world
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law describes how patent challenges have become even more important under the revised drug pricing framework in South Korea
-
Sponsored by AFD China Intellectual Property Law OfficeJie He, Jingjing Wu and Xia Zheng of AFD China Intellectual Property Law Office discuss trademark registrations and the obstacles to overcome to establish a successful trademark environment
-
Sponsored by Beijing Kangrui Law FirmXiaodong Ren and Xiaojun Liu of Beijing Kangrui Law Firm explain the techniques that legal teams can take during the evidence collection stages of IP disputes
